ENTRY       D01275                      Drug
NAME        Doxorubicin hydrochloride (JP18/USP);
            Adriacin (TN);
            Adriamycin (TN);
            Doxil (TN);
            Rubex (TN)
PRODUCT     DOXIL (Baxter Healthcare Corporation)
            DOXORUBICIN HYDROCHLORIDE (Pfizer Laboratories Div Pfizer)
            DOXORUBICIN HYDROCHLORIDE (Pfizer Laboratories Div Pfizer)
  GENERIC   ADRIAMYCIN (Hikma Pharmaceuticals USA)
            ADRIAMYCIN (Hikma Pharmaceuticals USA)
            ADRIAMYCIN (Hikma Pharmaceuticals USA)
            DOXORUBICIN HYDROCHLORIDE (Actavis Pharma)
            DOXORUBICIN HYDROCHLORIDE (Amneal Pharmaceuticals LLC)
            DOXORUBICIN HYDROCHLORIDE (Athenex Pharmaceutical Division)
            DOXORUBICIN HYDROCHLORIDE (BluePoint Laboratories)
            DOXORUBICIN HYDROCHLORIDE (BluePoint Laboratories)
            DOXORUBICIN HYDROCHLORIDE (Bryant Ranch Prepack)
            DOXORUBICIN HYDROCHLORIDE (Bryant Ranch Prepack)
            DOXORUBICIN HYDROCHLORIDE (Dr. Reddy's Laboratories)
            DOXORUBICIN HYDROCHLORIDE (Dr. Reddy's Laboratories)
            DOXORUBICIN HYDROCHLORIDE (Fresenius Kabi USA)
            DOXORUBICIN HYDROCHLORIDE (Gland Pharma Limited)
            DOXORUBICIN HYDROCHLORIDE (Hikma Pharmaceuticals USA)
            DOXORUBICIN HYDROCHLORIDE (Hikma Pharmaceuticals USA)
            DOXORUBICIN HYDROCHLORIDE (Hikma Pharmaceuticals USA)
            DOXORUBICIN HYDROCHLORIDE (Mylan Institutional LLC)
            DOXORUBICIN HYDROCHLORIDE (NorthStar RxLLC)
            DOXORUBICIN HYDROCHLORIDE (NorthStar RxLLC)
            DOXORUBICIN HYDROCHLORIDE (Northstar RxLLC)
            DOXORUBICIN HYDROCHLORIDE (Padagis US LLC)
            DOXORUBICIN HYDROCHLORIDE (Sagent Pharmaceuticals)
            DOXORUBICIN HYDROCHLORIDE (Sun Pharmaceutical Industries)
            DOXORUBICIN HYDROCHLORIDE (Sun Pharmaceutical Industries)
            DOXORUBICIN HYDROCHLORIDE (Zydus Lifesciences Limited)
            DOXORUBICIN HYDROCHLORIDE (Zydus Pharmaceuticals USA)
            DOXORUBICIN HYDROCHLORIDE LIPOSOME (Baxter Healthcare Corporation)
FORMULA     C27H29NO11. HCl
EXACT_MASS  579.1507
MOL_WEIGHT  579.9802
SOURCE      Streptomyces peucetius [TAX:1950]
CLASS       Antineoplastic
             DG01682  Anthracycline antineoplastic
             DG01529  Topoisomerase inhibitor
              DG01527  Topoisomerase II inhibitor
REMARK      Therapeutic category: 4235
            ATC code: L01DB01
            Chemical structure group: DG00696
            Product (DG00696): D01275<JP/US>
EFFICACY    Antineoplastic, Topoisomerase II inhibitor
  DISEASE   Ovarian cancer [DS:H00027]
            AIDS-related Kaposi's sarcoma [DS:H00041]
            Multiple myeloma [DS:H00010]
            Acute lymphoblastic leukemia [DS:H00001 H00002]
            Acute myeloblastic leukemia [DS:H00003]
            Hodgkin lymphoma [DS:H00007]
            Non-Hodgkin lymphoma [DS:H02418]
            Breast cancer [DS:H00031]
            Wilms' tumor [DS:H02301]
            Neuroblastoma [DS:H00043]
            Soft tissue sarcoma [DS:H02427]
            Ovarian carcinoma [DS:H00027]
            Transitional cell bladder carcinoma [DS:H00022]
            Thyroid carcinoma [DS:H00032]
            Gastric carcinoma [DS:H00018]
TARGET      TOP2 [HSA:7153 7155] [KO:K03164]
INTERACTION  
STR_MAP     map07042  Antineoplastics - agents from natural products
OTHER_MAP   map04976  Bile secretion
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
                L01DB Anthracyclines and related substances
                 L01DB01 Doxorubicin
                  D01275  Doxorubicin hydrochloride (JP18/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Doxorubicin
                D01275  Doxorubicin hydrochloride (JP18/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               423  Antibiotics
                4235  Anthracycline antibiotics
                 D01275  Doxorubicin hydrochloride (JP18/USP)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01682  Anthracycline antineoplastic
               DG00696  Doxorubicin
                D01275  Doxorubicin hydrochloride
              DG01529  Topoisomerase inhibitor
               DG01527  Topoisomerase II inhibitor
                DG00696  Doxorubicin
                 D01275  Doxorubicin hydrochloride
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Isomerases (EC5)
               DNA topoisomerase
                TOP2
                 D01275  Doxorubicin hydrochloride (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01275  Doxorubicin hydrochloride
              D01275  Doxorubicin hydrochloride for injection
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01275
            Drug groups [BR:br08330]
             Antineoplastic
              DG01682  Anthracycline antineoplastic
               DG00696  Doxorubicin
              DG01529  Topoisomerase inhibitor
               DG01527  Topoisomerase II inhibitor
                DG00696  Doxorubicin
DBLINKS     CAS: 25316-40-9
            PubChem: 7848338
            ChEBI: 31522
            LigandBox: D01275
            NIKKAJI: J262.563F
ATOM        40
            1   C8x C    23.4525  -12.6014
            2   C8x C    23.4525  -14.0018
            3   C8y C    24.6429  -14.7020
            4   C8y C    25.9033  -14.0018
            5   C8y C    25.9033  -12.6014
            6   C8x C    24.6429  -11.9012
            7   C5x C    27.0936  -14.7020
            8   C8y C    28.2840  -14.0018
            9   C8y C    28.2840  -12.6014
            10  C5x C    27.0936  -11.9012
            11  C8y C    29.5443  -14.7020
            12  C8y C    30.7347  -14.0018
            13  C8y C    30.7347  -12.6014
            14  C8y C    29.5443  -11.9012
            15  C1y C    31.9250  -14.7020
            16  C1x C    33.1854  -14.0018
            17  C1z C    33.1854  -12.6014
            18  C1x C    31.9250  -11.9012
            19  O2a O    24.6429  -16.1024
            20  C1a C    23.4525  -16.8026
            21  O5x O    27.0936  -16.1024
            22  O5x O    27.0936  -10.5008
            23  O1a O    29.5443  -10.5008
            24  O1a O    29.5443  -16.1024
            25  O2a O    31.9250  -16.1024
            26  C1y C    33.1154  -16.8026
            27  C5a C    34.3758  -11.9012
            28  C1b C    35.5661  -12.6014
            29  O1a O    36.7565  -11.9012
            30  O5a O    34.3758  -10.5008
            31  O1a O    34.3758  -13.3016
            32  C1x C    33.1154  -18.2030
            33  C1y C    34.3758  -18.9032
            34  C1y C    35.5661  -18.2030
            35  C1y C    35.5661  -16.8026
            36  O2x O    34.3758  -16.1024
            37  N1a N    34.3930  -20.3035
            38  C1a C    36.7818  -16.1073
            39  O1a O    36.7818  -18.8983
            40  X   Cl   28.4940  -18.6932
BOND        43
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    8  11 2
            13   11  12 1
            14   12  13 2
            15   13  14 1
            16    9  14 2
            17   12  15 1
            18   15  16 1
            19   16  17 1
            20   17  18 1
            21   13  18 1
            22    3  19 1
            23   19  20 1
            24    7  21 2
            25   10  22 2
            26   14  23 1
            27   11  24 1
            28   26  25 1 #Down
            29   15  25 1 #Down
            30   17  27 1 #Up
            31   27  28 1
            32   28  29 1
            33   27  30 2
            34   17  31 1 #Down
            35   26  32 1
            36   32  33 1
            37   33  34 1
            38   34  35 1
            39   35  36 1
            40   26  36 1
            41   33  37 1 #Up
            42   35  38 1 #Up
            43   34  39 1 #Up
///
